Article Details
Retrieved on: 2019-05-01 20:31:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Exane Derivatives decreased its stake in <b>Finisar</b> (FNSR) by 48.46% based on its latest 2018Q4 regulatory filing with the SEC. Exane Derivatives sold ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here